A kind of phospholipid chitosan drug delivery system and its preparation method and application

A delivery system, chitosan technology, applied in drug combination, nano-drug, digestive system, etc., can solve the problems of reduced encapsulation rate, leakage of natamycin, low encapsulation rate, etc.

Active Publication Date: 2021-08-17
BEIJING WEHAND BIO PHARMA CO LTD +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Especially some drugs with polar groups such as amino group, hydroxyl group, carbonyl group, carboxyl group, amide group, ester group, etc., may have low encapsulation efficiency, drug leakage, particle size, Zeta potential and other changes and become unstable , for example, R.S.Bhatta et al. [R.S.Bhatta, et al., International Journal of Pharmaceutics, 2012, 432 (1-2): 105-112] prepared natamycin (with hydroxyl, amino, carboxyl, ester group) The encapsulation efficiency of phospholipid / chitosan nanoparticles was 73.57±0.62%. When stored at 4°C for 60 days, the encapsulation efficiency decreased significantly, and natamycin leaked seriously

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of phospholipid chitosan drug delivery system and its preparation method and application
  • A kind of phospholipid chitosan drug delivery system and its preparation method and application
  • A kind of phospholipid chitosan drug delivery system and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055] 1. Preparation of baicalein-lipid complex

[0056] (1) Preparation of baicalein lipid complex I (baicalein: soybean lecithin (w / w)=1:3.5)

[0057] Take 1g of baicalein, 3.5g of soybean lecithin, add 40mL of tetrahydrofuran, compound at 40°C for 1 hour, remove the solvent by rotary evaporation, and dry in vacuum for more than 12 hours (20-30°C) to obtain baicalein lipid complex I, airtight Pack and store in the refrigerator.

[0058] (2) Preparation of baicalein lipid complex II (baicalein: soybean lecithin (w / w)=1:6)

[0059] Take 0.5g of baicalein and 3.0g of soybean lecithin, add 40mL of ethyl acetate, compound at 40°C for 1 hour, remove the solvent by rotary evaporation, and dry in vacuum for more than 12 hours (20-30°C) to obtain the baicalein lipid complex II, airtightly packaged and stored in the refrigerator.

[0060] 2. Preparation of baicalein lipoplex I-phospholipid / chitosan drug delivery system

[0061] (1) Dissolve low, medium and high viscosity chitosan...

Embodiment 2

[0073] 1. Preparation of paclitaxel lipoplex

[0074] (1) Preparation of paclitaxel lipoplex I (paclitaxel: egg yolk phospholipid (w / w)=1:6)

[0075] Take paclitaxel 0.5g, egg yolk phospholipid 3.0g, add tetrahydrofuran 100mL, compound at 40°C for 1 hour, remove the solvent by rotary evaporation, and dry in vacuum for more than 12 hours (20-30°C) to obtain paclitaxel lipid complex I, sealed package , stored in the refrigerator.

[0076] (2) Preparation of Paclitaxel Lipid Complex II (Paclitaxel:Cholesterol (w / w)=1:2)

[0077] Take 0.5g of paclitaxel and 1.0g of cholesterol, add 200mL of acetone preheated to 40°C, compound at 40°C for 2 hours, remove the solvent by rotary evaporation, and dry in vacuum for more than 12 hours (20-30°C) to obtain paclitaxel lipid compound Material II, airtightly packaged, stored in the refrigerator.

[0078] 2. Preparation of paclitaxel lipoplex II-phospholipid / chitosan drug delivery system

[0079] (1) low-viscosity chitosan is dissolved in ...

Embodiment 3

[0091] 1. Preparation of Chlorogenic Acid Lipid Complex

[0092] (1) Preparation of chlorogenic acid lipid complex I (chlorogenic acid: soybean lecithin (w / w)=1:2.5)

[0093] Take 0.5g of chlorogenic acid and 1.25g of soybean lecithin, add 50mL of absolute ethanol, compound at 40°C for 30 minutes, remove the solvent by rotary evaporation, and dry in vacuum for more than 12 hours (20-30°C) to obtain chlorogenic acid lipid compound Thing I, airtightly packaged, puts into the refrigerator for refrigerated preservation.

[0094] (2) Preparation of chlorogenic acid lipid complex II (chlorogenic acid:distearoylphosphatidylcholine (w / w)=1:2.2)

[0095] Take 1g of chlorogenic acid and 2.2g of distearoylphosphatidylcholine, add 50mL of absolute ethanol, compound at 40°C for 30 minutes, remove the solvent by rotary evaporation, and dry in vacuum for more than 12 hours (20-30°C), to obtain green Ortho-acid lipid complex II, airtightly packaged, stored in the refrigerator.

[0096] 2. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
Login to view more

Abstract

A phospholipid chitosan drug delivery system and its preparation method and application, the drug delivery system includes drug lipid complex and chitosan, the phospholipids in the drug delivery system come from free phospholipids and / or lipid complexes The phospholipids in the drug lipid complex do not include insulin. The drug delivery system can be used in oral, transdermal, mucosal, pulmonary inhalation and other drug delivery systems.

Description

technical field [0001] The invention relates to a novel phospholipid / chitosan drug delivery system and its preparation method and application. Background technique [0002] Phospholipid / chitosan nanoparticles (Lecithin / chitosannanoparticles, LCNs) is a kind of nanoparticle discovered by Italian scholar F.Sonvico et al. [Sonvico F.et al., Int J Pharm,2006,324:67-73] in 2006. Carrier, which is formed by self-assembly of negatively charged phospholipids and positively charged chitosan through charge interaction under certain conditions. [0003] Phospholipid / chitosan nanoparticles have attracted extensive attention from scholars at home and abroad in recent years due to their good biocompatibility, biodegradability, and bioadhesion. And so on, and its application in the food field has been in-depth research. [0004] According to Sonvico F. et al. report, phospholipid / chitosan nanoparticles are suitable for encapsulating lipophilic drugs. However, whether the drug is suitabl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K9/51A61K31/352A61K31/337A61K31/57A61K31/216A61K47/24A61K47/36
CPCA61K9/5123A61K9/5161A61K31/216A61K31/337A61K31/352A61K31/57A61K9/5192A61K9/127A61K47/24A61K47/28A61K45/00A61P31/04A61P31/10A61P31/12A61P29/00A61P43/00A61P37/02A61P39/06A61P17/18A61P17/16A61P35/00A61P5/00A61P9/12A61P3/06A61P9/10A61P31/14A61P19/10A61P1/16B82Y5/00B82Y40/00A61K47/36A61K9/51
Inventor 刘玉玲王玮珏董武军郝华珍夏学军黄岳升金毅群蒋玲敏周君卓
Owner BEIJING WEHAND BIO PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap